Also, gastric cancer cell with CLDN18-ARHGAP fusion gene could activate PI3K/AKT-mTOR-FAS signaling, which enhances free fatty acid production of gastric cancer cells to favor the survival of Treg cells and contribute to immune suppression. This evidence concerns the gene MTOR and gastric cancer.